Suchergebnisse - "Asgharnejad, Mahnaz"

PubPharm (69)

1

Population pharmacokinetics, enzyme occupancy, and pharmacodynamic modeling of soticlestat in patients with developmental and epileptic encephalopathies

enthalten in: Clinical and translational science | 2024

von Yin, W. | Facius, A. | Asgharnejad, M. | +2

2

Investigation of the absolute bioavailability, mass balance, metabolism, and excretion of the cholesterol 24-hydroxylase inhibitor soticlestat in healthy volunteers

enthalten in: British journal of clinical pharmacology | 2024

von Yin, W. | Ballard, T. | Zhu, S. | +9

3

Investigation of the absolute bioavailability, mass balance, metabolism, and excretion of the cholesterol 24‐hydroxylase inhibitor soticlestat in healthy volunteers

enthalten in: British Journal of Clinical Pharmacology | 2024

von Yin, W. | Ballard, T. | Zhu, S. | +9

4

Population pharmacokinetics, enzyme occupancy, and pharmacodynamic modeling of soticlestat in patients with developmental and epileptic encephalopathies

enthalten in: Clinical and Translational Science | 2024

von Yin, W. | Facius, A. | Asgharnejad, M. | +2

5

TREATMENT FOR DEPRESSION

enthalten in: Europäisches Patentamt | 2023

von PATHI JAGANNATHAM NAGA VENKATESHA MURTHY | ASGHARNEJAD MAHNAZ | XU LIN

6

METHODS OF TREATING NEUROLOGICAL DISEASES

enthalten in: Europäisches Patentamt | 2023

von ASGHARNEJAD MAHNAZ | YIN WEI | PATHI JAGANNATHAM NAGA VENKATESHA MURTHY

7

Randomized controlled study to evaluate the efficacy and safety of soticlestat as adjunctive therapy in adults with complex regional pain syndrome

enthalten in: Pain medicine (Malden, Mass.) | 2023

von Ratcliffe, S. | Arkilo, D. | Asgharnejad, M. | +2

8

Population pharmacokinetics, enzyme occupancy, and 24S-hydroxycholesterol modeling of soticlestat, a novel cholesterol 24-hydroxylase inhibitor, in healthy adults

enthalten in: Clinical and translational science | 2023

von Yin, W. | Facius, A. | Wagner, T. | +4

9

The D-amino acid oxidase inhibitor luvadaxistat improves mismatch negativity in patients with schizophrenia in a randomized trial

enthalten in: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology | 2023

von O'Donnell, P. | Dong, C. | Murthy, V. | +12

10

Efficacy, safety, and tolerability of soticlestat as adjunctive therapy for the treatment of seizures in patients with Dup15q syndrome or CDKL5 deficiency disorder in an open-label signal-finding phase II study (ARCADE)

enthalten in: Epilepsy & behavior : E&B | 2023

von Demarest, S. | Jeste, S. | Agarwal, N. | +4

1
2
3
4
5
6
7
Nächster »
[7]